This has to be a joke. They released an announcement to say that Halucenex, who CPH don't own and may never will, slightly tweaked the scope of participants in a clinical trial? And they even describe it as a "strategic decision"? Surely this breaches the new non-ramping rules for the ASX, no?
Talk about desperate times.
- Forums
- ASX - By Stock
- CPH
- Ann: Halucenex Expands its Clinical Trials Plans
Ann: Halucenex Expands its Clinical Trials Plans, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)